1326 / 1674
Escalation and de-escalation in EBC
treatment
ADD (+)
WITHDRAW (-)
ER +
•
ET 10 yrs vs 5
(high risk)
•
LHRH (high risk)
•
No CT in cH/gL
HER2+
Neratinib ?
Not yet
TN
Dose-dense
No cht in good-
prognosis subtypes
|
|
1326 / 1674
1326 / 1674
Escalation and de-escalation in EBC
treatment
ADD (+)
WITHDRAW (-)
ER +
•
ET 10 yrs vs 5
(high risk)
•
LHRH (high risk)
•
No CT in cH/gL
HER2+
Neratinib ?
Not yet
TN
Dose-dense
No cht in good-
prognosis subtypes